Clinical Trials Browser

Phase 2/3 × Interventional × Clinical Trials, Phase II as Topic × Clear all

NCT06861777 2025-03-11

Total Neoadjuvant Therapy Combined With Adebrelimab in Locally Advanced Resectable ESCC

Phase 2/3 Not yet recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma